185 related articles for article (PubMed ID: 29722334)
1. Antibiotics De-Escalation in the Treatment of Ventilator-Associated Pneumonia in Trauma Patients: A Retrospective Study on Propensity Score Matching Method.
Li H; Yang CH; Huang LO; Cui YH; Xu D; Wu CR; Tang JG
Chin Med J (Engl); 2018 May; 131(10):1151-1157. PubMed ID: 29722334
[TBL] [Abstract][Full Text] [Related]
2. A retrospective study of antibiotic de-escalation in patients with ventilator-associated pneumonia in Malaysia.
Khan RA; Aziz Z
Int J Clin Pharm; 2017 Aug; 39(4):906-912. PubMed ID: 28643112
[TBL] [Abstract][Full Text] [Related]
3. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
Eachempati SR; Hydo LJ; Shou J; Barie PS
J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
[TBL] [Abstract][Full Text] [Related]
4. Safety of De-Escalating Empiric Antimicrobial Agents in Trauma Patients with Indigenous Oral Flora Ventilator-Associated Pneumonia.
Kaylor DM; Caminiti N; Harbrecht B; McPheeters C; Scherrer LA
Surg Infect (Larchmt); 2022 Aug; 23(6):597-603. PubMed ID: 35917387
[No Abstract] [Full Text] [Related]
5. An early predictor of the outcome of patients with ventilator-associated pneumonia.
Huang KT; Tseng CC; Fang WF; Lin MC
Chang Gung Med J; 2010; 33(3):274-82. PubMed ID: 20584505
[TBL] [Abstract][Full Text] [Related]
6. The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study.
Chang Y; Jeon K; Lee SM; Cho YJ; Kim YS; Chong YP; Hong SB
J Korean Med Sci; 2021 Oct; 36(41):e251. PubMed ID: 34697926
[TBL] [Abstract][Full Text] [Related]
7. Empiric, broad-spectrum antibiotic therapy with an aggressive de-escalation strategy does not induce gram-negative pathogen resistance in ventilator-associated pneumonia.
Hibbard ML; Kopelman TR; O'Neill PJ; Maly TJ; Matthews MR; Cox JC; Vail SJ; Quan AN; Drachman DA
Surg Infect (Larchmt); 2010 Oct; 11(5):427-32. PubMed ID: 20818984
[TBL] [Abstract][Full Text] [Related]
8. Ventilator-associated pneumonia: the influence of bacterial resistance, prescription errors, and de-escalation of antimicrobial therapy on mortality rates.
Souza-Oliveira AC; Cunha TM; Passos LB; Lopes GC; Gomes FA; Röder DV
Braz J Infect Dis; 2016; 20(5):437-43. PubMed ID: 27473893
[TBL] [Abstract][Full Text] [Related]
9. De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate.
Giantsou E; Liratzopoulos N; Efraimidou E; Panopoulou M; Alepopoulou E; Kartali-Ktenidou S; Manolas K
Intensive Care Med; 2007 Sep; 33(9):1533-40. PubMed ID: 17549458
[TBL] [Abstract][Full Text] [Related]
10. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
[TBL] [Abstract][Full Text] [Related]
11. Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia.
Joung MK; Lee JA; Moon SY; Cheong HS; Joo EJ; Ha YE; Sohn KM; Chung SM; Suh GY; Chung DR; Song JH; Peck KR
Crit Care; 2011; 15(2):R79. PubMed ID: 21366903
[TBL] [Abstract][Full Text] [Related]
12. [Application value of lung ultrasound in the diagnosis and severity assessment of ventilator-associated pneumonia].
Li J; Zhu J; Liu Q; Ma J; Li C; Wang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jun; 33(6):702-707. PubMed ID: 34296690
[TBL] [Abstract][Full Text] [Related]
13. Reinventing the wheel: Impact of prolonged antibiotic exposure on multidrug-resistant ventilator-associated pneumonia in trauma patients.
Lewis RH; Sharpe JP; Swanson JM; Fabian TC; Croce MA; Magnotti LJ
J Trauma Acute Care Surg; 2018 Aug; 85(2):256-262. PubMed ID: 29664891
[TBL] [Abstract][Full Text] [Related]
14. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
[TBL] [Abstract][Full Text] [Related]
15. Microorganisms and clinical outcomes of early- and late-onset ventilator-associated pneumonia at Srinagarind Hospital, a tertiary center in Northeastern Thailand.
Arayasukawat P; So-Ngern A; Reechaipichitkul W; Chumpangern W; Arunsurat I; Ratanawatkul P; Chuennok W
BMC Pulm Med; 2021 Jan; 21(1):47. PubMed ID: 33516213
[TBL] [Abstract][Full Text] [Related]
16. Trimethoprim-sulfamethoxazole as de-escalation in ventilator-associated pneumonia: a cohort study subanalysis.
Strazzulla A; Postorino MC; Youbong T; Rouyer M; Flateau C; Chakvetadze C; de Pontfarcy A; Pitsch A; Jochmans S; Belfeki N; Monchi M; Diamantis S
Eur J Clin Microbiol Infect Dis; 2021 Jul; 40(7):1511-1516. PubMed ID: 33625621
[TBL] [Abstract][Full Text] [Related]
17. Acute physiology and chronic health evaluation II score is a better predictor of mortality than IBMP-10 in patients with ventilator-associated pneumonia.
Wiskirchen DE; Kuti JL; Nicolau DP
Surg Infect (Larchmt); 2011 Oct; 12(5):385-90. PubMed ID: 22004437
[TBL] [Abstract][Full Text] [Related]
18. Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse.
Leone M; Garcin F; Bouvenot J; Boyadjev I; Visintini P; Albanèse J; Martin C
Crit Care Med; 2007 Feb; 35(2):379-85; quizz 386. PubMed ID: 17205011
[TBL] [Abstract][Full Text] [Related]
19. Impact of clinical severity index, infective pathogens, and initial empiric antibiotic use on hospital mortality in patients with ventilator-associated pneumonia.
Tseng CC; Liu SF; Wang CC; Tu ML; Chung YH; Lin MC; Fang WF
Am J Infect Control; 2012 Sep; 40(7):648-52. PubMed ID: 22243991
[TBL] [Abstract][Full Text] [Related]
20. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
Arnold HM; Sawyer AM; Kollef MH
Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
